Here are five things to know:
1. Globus issued roughly $625 million of revenue guidance compared to the estimated $624.42 consensus revenue mark.
2. The company opened Wednesday, Feb. 28, 2017 at $27.81. Its one-year low is $19.25 and its one-year high is $28.86.
3. On Feb. 27, Globus reported $0.31 earnings per share for the quarter, missing the $0.33 estimate by $0.02. However, the company’s revenue of $151.59 million for the quarter exceeded analysts’ expectations of $149.30 million. Revenue for the quarter was up 6.3 percent on a year-over-year basis.
4. Zacks Investment Research, JMP Securities, Oppenheimer Holdings Inc., and William Blair recently cut shares of Globus.
5. One analyst has rated the company’s stock with a sell rating, 10 have given a hold rating and three have given a buy rating. Globus has a consensus price target of $25.60.
More device articles:
10 things to know about Stryker
Drs. Dom Coric, Michael Fehlings to present on INSPIRE study: 4 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
